All seven proposals approved at Mereo BioPharma 2024 AGM; director re-elections pass with >91% support

Mereo BioPharma Group plc

Annual report adopted with 99.66% of votes cast in favor; PwC reappointed as auditor (99.60% support).
Dr. Denise Scots-Knight re-elected as director (91.13% for), Dr. Jeremy Bender re-elected (92.46% for), Dr. Anders Ekblom re-elected (94.12% for).
Directors' remuneration report approved with 98.63% of votes cast in favor.
All votes based on 536,018,312 ordinary shares represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.